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Microbiota-Related Changes in Unconjugated Fecal Bile Acids Are
Associated With Naturally Occurring, Insulin-Dependent Diabetes
Mellitus in Dogs
Abstract
Diabetes mellitus (DM) in humans has recently been associated with altered intestinal microbiota. The
consequences of intestinal dysbiosis, such as increased intestinal permeability and altered microbial
metabolites, are suspected to contribute to the host inflammatory state and peripheral insulin resistance.
Human diabetics have been shown to have changes in bile acid (BA) metabolism which may be detrimental to
glycemic control. The purpose of this study was to examine BA metabolism in dogs with naturally-occurring,
insulin-dependent DM and to relate these findings to changes in the intestinal microbiota. A prospective
observational study of adult dogs with a clinical diagnosis of DM (n = 10) and healthy controls (HC, n = 10)
was performed. The fecal microbiota were analyzed by 16S rRNA gene next-generation (Illumina)
sequencing. Concentrations of fecal unconjugated BA (f UBA) were measured using gas chromatography and
mass spectrometry. Analysis of bacterial communities showed no significant difference for any of the alpha-
diversity measures between DM vs. HC dogs. Principal coordinate analysis based on unweighted Unifrac
distance metric failed to show significant clustering between dog groups (ANOSIMUnweighted: R = 0.084; p
= 0.114). However, linear discriminate analysis effects size (LEfSe) detected differentially abundant bacterial
taxa (α = 0.01, LDA score >2.0) on various phylogenetic levels. While Enterobacteriaceae was overrepresented
in dogs with DM, the proportions of Erysipelotrichia, Mogibacteriaceae, and Anaeroplasmataceae were
increased in HC dogs. Dogs with DM had increased concentration of total primary f UBA compared to HC
dogs (p = 0.028). The concentrations of cholic acid and the cholic acid percentage of the total f UBA were
increased (p = 0.028 and p = 0.035, respectively) in the feces of DM dogs relative to HC dogs. The levels of
lithocholic acid (both absolute value and percentage of the total f UBA) were decreased (p = 0.043 and p <
0.01, respectively) in DM dogs vs. HC dogs. Results indicate that dogs with DM have both intestinal dysbiosis
and associated f UBA alterations. The pattern of dysbiosis and altered BA composition is similar to that seen in
humans with Type 2 DM. The dog represents a novel large animal model for advancing translational medicine
research efforts (e.g., investigating pathogenesis and therapeutics) in DM affecting humans.
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Diabetes mellitus (DM) in humans has recently been associated with altered intestinal
microbiota. The consequences of intestinal dysbiosis, such as increased intestinal
permeability and altered microbial metabolites, are suspected to contribute to the
host inflammatory state and peripheral insulin resistance. Human diabetics have been
shown to have changes in bile acid (BA) metabolism which may be detrimental
to glycemic control. The purpose of this study was to examine BA metabolism in
dogs with naturally-occurring, insulin-dependent DM and to relate these findings to
changes in the intestinal microbiota. A prospective observational study of adult dogs
with a clinical diagnosis of DM (n = 10) and healthy controls (HC, n = 10) was
performed. The fecal microbiota were analyzed by 16S rRNA gene next-generation
(Illumina) sequencing. Concentrations of fecal unconjugated BA (fUBA) were measured
using gas chromatography and mass spectrometry. Analysis of bacterial communities
showed no significant difference for any of the alpha-diversity measures between DM
vs. HC dogs. Principal coordinate analysis based on unweighted Unifrac distance
metric failed to show significant clustering between dog groups (ANOSIMUnweighted: R
= 0.084; p = 0.114). However, linear discriminate analysis effects size (LEfSe) detected
differentially abundant bacterial taxa (α = 0.01, LDA score >2.0) on various phylogenetic
levels. While Enterobacteriaceae was overrepresented in dogs with DM, the proportions
of Erysipelotrichia, Mogibacteriaceae, and Anaeroplasmataceae were increased in HC
dogs. Dogs with DM had increased concentration of total primary fUBA compared to
HC dogs (p = 0.028). The concentrations of cholic acid and the cholic acid percentage
of the total fUBA were increased (p = 0.028 and p = 0.035, respectively) in the feces
of DM dogs relative to HC dogs. The levels of lithocholic acid (both absolute value and
percentage of the total fUBA) were decreased (p = 0.043 and p < 0.01, respectively) in
DM dogs vs. HC dogs. Results indicate that dogs with DM have both intestinal dysbiosis
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and associated fUBA alterations. The pattern of dysbiosis and altered BA composition
is similar to that seen in humans with Type 2 DM. The dog represents a novel large
animal model for advancing translational medicine research efforts (e.g., investigating
pathogenesis and therapeutics) in DM affecting humans.
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INTRODUCTION
The intestinal microbiota is increasingly recognized as a pivotal
environmental factor contributing to development of metabolic
diseases in humans, including obesity, insulin resistance and type
2 diabetes mellitus (T2DM) (1–3). Microbes in the gut play an
important role in metabolic disturbances by increasing energy
extraction from ingested foods, regulating host metabolism and
generating low-grade intestinal inflammation. High throughput
16S rRNA sequencing of the gut microbiota of ob/obmice found
that their obesity was associated with significant shifts in relative
abundance of select bacterial taxa (e.g., Bacteroidetes decreased
while Firmicutes were increased) vs. lean controls (4). These same
investigators demonstrated that the proportion of Bacteroidetes
in obese humans was decreased as compared to intestinal
populations in lean humans (5). However, other studies aimed at
evaluating altered gut microbial composition and its association
with human diabetes have produced conflicting results (3, 6–8).
The intestinal microbiota also influences metabolism of
bile acids (BA). Cholic acid and chenodeoxycholic acid are
primary BA synthesized from cholesterol in the liver. Following
ingestion of a fat- and protein-rich meal, primary BA travel
down the intestines where they are then modified by anaerobic
bacteria into different secondary BA, primarily deoxycholic and
lithocholic acids. Accumulating evidence demonstrates that BA
are important signaling molecules regulating hepatic glucose
metabolism via farsenoid X receptor (FXR)-mediated pathways
(9–11). Primary BA are also involved in energy metabolism
due to their interaction with G protein coupled BA receptor
(TGR-5) activation and release of glucagon-like peptide-1 (GLP-
1) (10, 12). As compared to non-obese healthy subjects, the
fasting serum of obese humans contains decreased primary BA
but increased secondary BA concentrations (13).Whether similar
microbiota-related changes in the bile acid profile are associated
with naturally occurring, insulin-dependent diabetes mellitus
(DM) in dogs has not been previously investigated.
With this study, we evaluated the fecal unconjugated bile
acid (fUBA) profiles of diabetic vs. healthy control dogs, and
hypothesized that diabetic dogs would have perturbations in
fecal bile acids similar to those reported in humans with T2DM,
including alterations in their intestinal microbiota.
MATERIALS AND METHODS
Ethical Animal Use
The collection and analysis of blood and fecal samples from
healthy dogs and dogs with spontaneous DM were previously
approved by the Iowa State University Institutional Animal Care
and Use Committee. Written informed consent was obtained
from all owners of healthy and DM dogs enrolled in this trial
(IACUC Log number: 9-14-7859).
Animals and Enrollment
Dogs with naturally occurring, insulin-dependent DM (n = 10)
and healthy control dogs (HC, n = 10) were enrolled from
the hospital population at the ISU Lloyd Veterinary Medical
Center (2014–2016). Dogs with DM were diagnosed on the
basis of historical polyuria-polydipsia, change in appetite, and
weight loss accompanied by supportive laboratory abnormalities
including sustained hyperglycemia, hypercholesterolemia, and
glucosuria (14). Dogs with diabetes were enrolled if they were
>2 years of age and weighed >6 kg, were fasted overnight (12 h
minimum) prior to diagnostic sampling, had no discernible
other diseases (including bacterial urinary tract infection with
results confirmed by urine culture/susceptibility testing) and
received no medications (including antibiotics) within 3 weeks
of presentation.
Control dogs were between 2 and 9 years of age and
judged to be healthy on the basis of history and normal
physical examination. Additionally, HC dogs could not have
received antibiotics for a period of 6 months prior to diagnostic
sampling nor had any other medications administered other than
prophylactic flea/tick/heartworm preventatives. All HC dogs
were fasted for at least 12 h before samples were obtained.
The majority (n = 7) of DM dogs were fed a low-fat
weight reducing diet1 and three DM dogs were fed commercial
maintenance rations. In these instances, dogs with DM were fed
low-fat, high-fiber diets to combat obesity and to facilitate insulin
regulation (15). Control dogs were fed either a commercial
maintenance ration (n= 5), commercial elimination diet (n= 2),
or a low-fat weight reducing diet1,2 (n= 3). None of the dogs had
a history of antibiotic administration for at least 6 months prior
to sample collection.
Sample Collection
Blood was collected from both groups of dogs in the
mornings by routine venipuncture using the jugular or
cephalic veins. Serum was separated quickly within 15min of
collection and archived at −80◦C until laboratory analysis.
Fecal samples were obtained by digital extraction following
phlebotomy in most (17/20) dogs. In some instances, clients
brought in fresh fecal samples (contained in a plastic bag)
which had been voided naturally during the morning of
1Hill’s prescription diet w/d.
2Purina Pro Plan Veterinary Diet OM.
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diagnostic sampling. In these instances, feces were maintained
chilled by refrigeration (<4 h) until archived at −80◦C for
later analysis.
DNA Isolation and Sequencing of 16S
rRNA Genes
Total bacterial DNA was extracted from canine stool samples
(10 DM and 10 control dogs) using a MoBio Power soil
DNA isolation kit (MoBio Laboratories, USA) following the
manufacturer’s instructions. DNA concentration and quality
in the extracts was determined using a NanoDrop 1000
spectrophotometer. Sequencing of the V4 region of the
16S rRNA gene primers 515F (5′-GTGCCAGCMGCCGCG
GTAA-3′) to 806R (5′-GGACTACVSGGGTATCTAAT-3′′) was
performed using Illumina sequencing at the MR DNA laboratory
(www.mrdnalab.com, Shallowater, TX, USA).
The obtained sequences were processed and analyzed
using QIIME v 1.9 (16) as previously described (17), and
were uploaded to Sequence Read Archive at NCBI with
accession number SRP122536. Briefly, sequence data was first
demultiplexed, quality filtered using the default settings in
QIIME, chimeras were filtered from the sequence set using
USEARCH against the 97% clustered representative sequences
from the Greengenes v 13.8 database, while remaining sequences
were clustered into Operational Taxonomic Units (OTUs)
by using an open reference approach in QIIME (18). Prior
to downstream analysis, sequences assigned as chloroplast,
mitochondria, and low abundance OTUs, containing <0.01%
of the total reads in the dataset were removed. All samples
were rarefied to 97,980 sequences for even depth of analysis.
Alpha diversity measures included Chao1, Shannon diversity,
and observed OTUs (observed species). Beta diversity was
evaluated with the phylogeny based UniFrac distance metric
and visualized using Principal Coordinate Analysis (PCoA)
plots. Bray-Curtis dissimilarity was also calculated from the
data set.
Fecal Unconjugated Bile Acids
The fecal unconjugated bile acids (fUBA) quantified were
cholic acid (CA), chenodeoxycholic acid (CDCA), lithocholic
acid (LCA), deoxycholic acid (DCA), and ursodeoxycholic
acid (UDCA). For the identification and quantification of
unconjugated bile acids, the protocol was adapted and modified
from methods previously described (19, 20). Unconjugated
CA, CDCA, LCA, DCA, and UDCA were purchased from a
commercial supplier (Sigma-Aldrich, St. Louis, MO). Deuterated
internal standards CA-d4 and LCA-d4 were purchased fromCDN
Isotopes (Quebec, Canada). Hydrochloric acid (37% American
Chemical Society reagent), hexane [for high-performance
liquid-chromatography (HPLC)], 1-butanol for HPLC, and
derivatization agent (Supelco’s R© Sylon HTP HMDS + TCMS +
Pyridine, 3:1:9 Kit) were used for preparation of trimethylsilyl
ether (TMS) and butyl ester bile acid derivatives.
Naturally voided fecal samples were collected from healthy
dogs and dogs with DM. Approximately 0.5 g of wet feces was
aliquoted into a tube (5mL, 57 × 15.3mm, polypropylene,
Sarstedt, Nümbrecht, Germany) using a spatula (Smart Spatula,
TABLE 1 | Patient characteristics.
Group Age (years) Sex Weight (kg) BCS (0–9)
A. PATIENT DEMOGRAPHICS
Healthy 6 F 23 6
Healthy 9 F 17 6
Healthy 8 F 11 4
Healthy 8 M 7 5
Healthy 5 F 5 6
Healthy 6 F 6 6
Healthy 4 M 13 7
Healthy 3 M 23 3
Healthy 3 M 30 6
Healthy 2 M 37 5
Diabetic 10 F 3 6
Diabetic 8 M 7 6
Diabetic 8 F 15 8
Diabetic 8 F 10 2
Diabetic 14 M 8 7
Diabetic 13 F 12 9
Diabetic 6 F 45 6
Diabetic 8 F 35 3
Diabetic 8 M 32 4
Diabetic 11 M 14 7
Parameter Healthy dogs Diabetic dogs
B. CANINE GROUP COMPARISONS
No. of females/no. of males 5/5 6/4
Mean age (years) 5.4 9.4*
Mean weight (kg) 8.0 17.4
Mean BCS (0–9) 5.4 5.8
*p < 0.05; BCS, body condition score.
USA Scientific, Ocala, FL). Fecal samples were kept frozen at
−80◦C and then lyophilized overnight (Labconco FreeZone 2.5
Plus, Kansas City, MO). Samples were then pulverized and
aliquoted using a spatula (Smart Spatula, USA Scientific, Ocala,
FL) into disposable glass centrifuge tubes (5mL, Kimble-Chase,
Rockwood, TN). Aliquots of 10–15mg of lyophilized feces were
used, and concentrations of bile acids were later back calculated
according to the precise weight of each aliquot. A total volume
of 200 µL of butanol containing the internal standards CA-d4
and LCA-d4 was added to each fecal sample. Twenty microliters
of HCl were then added for a final volume of 220 µL and
vortexed for 30 s. Samples were then capped and incubated at
65◦C for 4 h. Next, samples were evaporated under nitrogen gas
until dryness at 65◦C for ∼25min. Two-hundred microliters of
TMS-derivatization agent were then added to the sample and
incubated at 65◦C for 30min. Following incubation, samples
were again evaporated under nitrogen gas until dryness at 65◦C
(∼25min). Samples were then resuspended in 200 µL of hexane,
vortexed briefly then centrifuged for 10min at 3,200 rcf. A 100µL
aliquot was transferred to a GC/MS vial insert (250 µL glass with
polymer feet, Agilent, Santa Clara, CA) and the vial was capped
for further downstream analysis.
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Gas chromatography (GC) and mass spectrometry (MS)
was used (6890N and 5975 inert Mass Selective Detector,
Agilent, Santa Clara, CA). The instrument was equipped with an
autosampler (7683 Series, Agilent, Santa Clara, CA). A capillary
column (DB-1ms Ultra Inert, Agilent, Santa Clara, CA) was used
with the following dimensions: length: 30m, diameter: 0.250mm,
film: 0.25µm. A 20:1 split ratio was utilized after a 1 µL sample
injection with an inlet temperature of 250◦C. After injection,
oven temperature was held at 150◦C for 1min, then ramped
at 21◦C per minute to a final temperature of 276◦C then held
at that temperature for 21min. Post-data acquisition, the oven
was heated to 325◦C for 3min for post-run column cleaning.
Helium was used as the carrier gas at a nominal flow rate of 1
mL/min. Flow varied slightly to maintain a retention time lock
of cholestane-d4 set to elute at 11.4min. Mass spectral data was
analyzed using ChemStation (Agilent’s Enhanced Data Analysis
in MSD version D.02.002.275). Use of this assay demonstrating




An LPS test was performed to quantitate the production of
Gram-negative bacterial endotoxin associated with low-grade
intestinal inflammation in insulin-dependent states of DM dogs
(22, 23). Serum samples from 10 control and 10 DM dogs
were analyzed for their concentration of LPS using the LAL
FIGURE 1 | Summary of alpha diversity measures.
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Chromogenic Endotoxin Quantification Kit according to the
manufacturer’s instructions.
Statistical Analysis
Normality was tested using Shapiro-Wilk for all measurements
(or variables) in the fUBA dataset. When the assumption did
not hold, the non-parametric Mann-Whitney test was used
for comparison of the groups (R software version 3.5.1, R
Foundation for Statistical Computing, Vienna, Austria, and
JMP 10, SAS software Inc.). A Fisher’s Exact Test was
used to test for proportions when evaluating confounding
factors, such as sex distribution between healthy control
(HC) dogs and dogs with DM. A statistical software package
(GraphPad Prism version 5.04 forWindows, GraphPad Software,
La Jolla California USA, www.graphpad.com) was used for
generating graphs.
For sequence data, linear discriminant analysis effect size
(LEfSe) was used to elucidate bacterial taxa different between
groups. LEfSe was used in the Galaxy workflow framework with
the parameters set at α = 0.01, LDA score = 2.0. Mann-Whitney
test (JMP Pro 11, SAS software Inc.) were performed and
adjusted for multiple comparison using a Benjamini-Hochberg
procedure with a false discovery rate (FDR) at each taxonomic
level. ANOSIM (analysis of similarity) test within PRIMER 6
software package (PRIMER-E Ltd., Luton, UK) was used to
analyze significant differences in microbial communities between
both dog groups.
The Mann-Whitney test was performed to compare
differences in LPS values between the two dog groups. For all
statistical analyses, a p-value < 0.05 was considered significant.
RESULTS
The patient demographic data for the canine cohorts is presented
in Table 1. In brief, gender, body weight, and body condition
score were comparable for diabetic and control groups. For
diabetic dogs, 1 dog was newly diagnosed with DM while
the remaining 9 dogs were receiving parenteral insulin and
considered to have poorly regulated DM based on persistent
clinical signs, results of blood (sustained hyperglycemia) and
urinalysis (marked glucosuria) testing. None of the enrolled
animals was ketoacidotic based on the absence of ketonuria and
metabolic acidosis on laboratory analysis.
The different diets fed to HC and DM dogs were dictated
by their overall health status and individual owner preference.
For example, the majority (n = 7) of DM dogs were obese (i.e.,
body condition score [BCS] > 5) and therefore were placed on
low-fat, high-fiber (i.e., standard) weight-reducing commercial
rations. Those DM dogs having normal body condition (n =
3) were fed canine commercial-derived maintenance rations
which do not promote weight loss when fed at recommended
levels. The HC dogs having normal body condition (n = 5)
were also fed commercial maintenance rations while 3 HC dogs
having an obese phenotype were fed low-fat weight-reducing
diets. Two HC dogs with past histories of adverse food reaction
were currently fed commercial elimination diets at the time
of enrollment.
Analysis of bacterial communities showed no significant
difference for any of the alpha-diversity measures between DM
dogs vs. HC dogs (Figure 1). Principal coordinate analysis (PCA)
based on unweighted Unifrac distance metric did not reveal
significant clustering between dog groups (ANOSIM Unweighted:
R = 0.084, p = 0.114; ANOSIMweighted: R = 0.074, p = 0.131;
Figure 2). Calculation of Bray-Curtis dissimilarity was significant
(i.e., R = 0.132, p = 0.038). PCA based on unweighted Unifrac
distance metric was compared using ANOSIM to address
confounding factors, such as administration of antibiotics,
body condition score, diet, concurrent health issues, and sexual
status. None of these comparisons reached statistical significance
between comparison groups. However, linear discriminate
analysis effects size (LEfSe) detected differentially abundant
bacterial taxa (α= 0.01, LDA score>2.0) on various phylogenetic
levels (Figure 3). While the family Enterobacteriaceae was
overrepresented in dogs with DM, the proportions of the
class Erysipelotrichia, and families Mogibacteriaceae, and
Anaeroplasmataceae were increased in HC dogs. Similarly, on a
FIGURE 2 | Principal coordinate analysis (PCoA) plot showing clustering of microbial communities from feces of healthy and diabetic dogs (red = diabetic, blue =
healthy). The microbiome (beta diversity) of healthy dogs did not differ from that of diabetic dogs (ANOSIM; p = 0.114).
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FIGURE 3 | Linear discriminant analysis effect size (LefSe) of bacterial taxa and their association with different canine groups. Only LefSe values >2 are shown.
species level, the abundance of an unclassified species belonging
to Enterobacteriaceae family was most strongly associated
with dogs having DM, while the abundance of Lactobacillus
reuteri and Bacteroides plebeius were most strongly associated
with HC dogs. Univariate analysis confirmed these findings,
as the same bacterial groups were significantly (p < 0.05)
altered (Supplemental Table 1).
Analysis of serum LPS concentrations showed that DM dogs
had increased (p = 0.0187) circulatory levels of LPS vs. healthy
dogs (Figure 4).
Dogs with DM had increased concentration of total primary
fUBA compared to HC dogs (p = 0.028; Table 2). The
concentrations of CA and the CA percentage of the total fUBA
were increased (p = 0.029 and p = 0.036, respectively) in the
Frontiers in Veterinary Science | www.frontiersin.org 6 June 2019 | Volume 6 | Article 199
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FIGURE 4 | Serum LPS concentrations (EU/ml) in healthy controls (HC) vs.
dogs with diabetes mellitus (DM).
TABLE 2 | Fecal bile acid parameters between cohorts.







Total primary BA 0.0976
Total secondary BA 0.0772
Secondary to primary ratio 0.0429
Primary to secondary ratio 0.0429
Cholic acid % of Total 0.0510
Chenodeoxycholic acid % of Total 0.8829
Lithocholic acid % of Total 0.0036
Deoxycholic acid % of Total 0.2538
Ursodeoxycholic acid % of Total 0.1851
Total primary BA % of Total 0.0429
Total secondary BA% of Total 0.0429
Shaded value indicates a fUBA of p< 0.05 indicating significant difference between canine
groups. fUBA, fecal unconjugated bile acid.
feces of DM dogs relative to HC dogs. The levels of LCA (both
absolute value and percentage of the total fUBA) were decreased
(p = 0.043 and p = 0.01, respectively) in DM dogs vs. HC dogs
(Figure 5).
DISCUSSION
Alterations in gut microbiota composition have been linked to
the development of human metabolic diseases, including both
T1DM and T2DM (2, 3, 24, 25). The physiologic interplay
between the intestinal microbiota and BA metabolism indicates
that dysbiosis may be accompanied by altered BA homeostasis,
thereby contributing to the metabolic dysregulation seen in DM.
Dogs develop naturally-occurring, insulin-dependent DM which
may also be associated with dysbiosis and altered bile acid
metabolism, suggesting that theymay serve as a clinically relevant
model for investigating human disease.
We have now demonstrated that canine insulin-dependent
DM is associated with changes in the composition of the
intestinal microbiota evident from the family to species levels.
In performing LEfSe analysis, we detected numerous bacterial
taxa that were differentially abundant (e.g., LDA score >2.0)
between dog groups. This included the relative abundance
of family Enterobacteriaceae which was overrepresented
while the abundance of subclass Erysipelotrichia, and of
families Mogibacteriaceae, and Anaeroplasmataceae were
underrepresented in DM dogs as compared to HC dogs. In
support of our findings, other animal studies have shown that
type 2 diabetic mice harbor reduced abundance of Bacteroides-
related bacteria that are linked to endotoxemia-induced
inflammation. Of interest, separate studies involving T2DM
patients have shown differences in the relative abundance
of select bacterial groups including the Bacteroidetes,
Proteobacteria, and Clostridia spp (3, 26). While differences
in gut microbial composition of human T2DM patients were
observed between these different studies, one consistent finding
was a decreased abundance of butyrate-producing bacteria
(3, 27–29). This inconsistency regarding which bacteria are
significantly altered in T2DM was later explained by the
administration of metformin, a commonly administered glucose
lowering drug (30).
It is now well-recognized that changes in the gut microbiota
composition contribute to the development of metabolic
endotoxemia (2, 24, 31). Specific compositional changes, caused
by enrichment of Gram-negative species, may modulate host
inflammatory activity through increased lipopolysaccharide
(LPS) absorption. Importantly, the DM dogs in our study were
observed to have increased abundance of Gammaproteobacteria
and elevated serum LPS concentrations, similar to humans with
T2DM (3). The LPS component of Gram negative bacteria acts as
an immunodominant antigen which binds to toll-like receptor 4
(TLR-4) to trigger immune system activation (32–34) which has
been previously reported in dogs (35). Interestingly, compared
to HC dogs, serum LPS concentrations in DM dogs of the
present study were elevated supporting the presence of metabolic
endotoxemia. While we anticipated even higher levels of LPS to
be present in DM dogs, the magnitude of serum elevation may
have been influenced by the fact that most (7/10) DM dogs were
being fed low-fat, weight reducing rations at the time of trial
enrollment (36).
Bile acids have been previously investigated for their role in
metabolic homeostasis and also for their well-known functions in
lipid digestion (37). Distinct patterns of altered BA metabolism
have been observed in rodent models and humans with T2DM,
including increased fasting taurine-conjugated BA (T-BA) and
post-prandial total BA responses (38, 39), increased urinary
BA excretion (40), perturbations in serum BA metabolomic
Frontiers in Veterinary Science | www.frontiersin.org 7 June 2019 | Volume 6 | Article 199
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FIGURE 5 | Comparison of primary and secondary fecal unconjugated bile acids in canine cohorts.
signature (41), and changes in bile acid metabolism present
in non-obese, spontaneously diabetic (NOD) mice (42). In our
study, we observed changes in both primary and secondary
fUBA in insulin-dependent DM dogs, characterized by increased
total primary fUBA with increased concentrations of CA and
the CA percentage of the total fUBA, while the levels of LCA
(both absolute value and percentage of the total fUBA) were
decreased in DM dogs vs. HC dogs. Whereas, our data show
similarities (43) and differences (13) to studies performed in
humans, they all imply a distinct link between impaired glucose
homeostasis and altered BA pool composition in diabetic-
susceptible individuals.
The relationship between host-microbiota interactions and
bile acids is complex and bidirectional. Microbial metabolism of
BA involves a number of reactions including BA deconjugation
by species having bile salt hydrolase (BSH) activity, 7-
dehydroxylation of primary BA into secondary BA, and the
generation of iso-BA (i.e., oxo- or keto-BA) by bacteria
containing hydroxysteroid dehydrogenases (HSDHs) (44–50).
As a result of altered BA composition, different BA modulate
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downstream signaling events through activation of receptors
FXR and TGR5 in metabolically active tissues (51). In contrast,
BA can modulate composition of the gut microbiota through
their direct antimicrobial actions (i.e., destroying bacterial
membranes by means of detergent properties) and indirectly
through FXR activation which promotes transcription of
antimicrobial (i.e., iNOS, IL-18) products (52). The ingestion of
high fat diets may also impact host health by modulating BA and
fecal microbiota composition to cause dysbiosis and local (gut
mucosal) and systemic inflammation (53, 54).
Surprisingly, data investigating the role of gut microbiota in
modulating the circulating BA pool in diabetic humans is sparse.
A single study has analyzed the expression of microbiota-derived
bile acid modification genes in humans with inflammatory bowel
disease and diabetes (55). It was shown that Firmicute-derived
bile salt hydrolase (BSH) genes and other BA modification
genes were significantly reduced in the feces of T2DM patients
relative to healthy controls. Similarly, other reports in animal
models and humans with T2DM have shown the significance
of gut microbial BSH genes in promoting positive physiologic
changes and alteration in the overall BA pool (38, 56, 57). In one
recent untargeted metabolomic study involving diabetic dogs,
the primary and secondary bile acids, taurochenodeoxycholic
acid, taurodeoxycholic acid, and tauroursodeoxycholic acid, were
significantly lower in dogs with diabetes as compared to healthy
dogs (58). While we observed reduced abundance of Firmicutes
in the feces of our DM dogs, analysis of microbial-derived BSH
or other BA modulating genes was not performed in this study.
There are only few published studies investigating canine BA
profiles in health and disease. Most recent data suggest a relevant
role for altered BA in canine chronic enteropathies. Honneffer
et al. (59) utilized an untargeted metabolomic approach to
identify several bile acid metabolites that were altered in the feces
of dogs diagnosed with idiopathic inflammatory bowel disease
(IBD). In a follow-up study to this report, Guard et al. (60)
performed longitudinal assessment of microbial dysbiosis, fUBA
concentrations and clinical disease activity in dogs with IBD that
were treated with glucocorticoids. In that study, secondary fUBA
were significantly decreased in IBD dogs and were accompanied
by fecal dysbiosis and increased disease activity. While both fecal
concentrations and the percentage of secondary fUBA increased
post-treatment in IBD dogs, fecal microbial imbalances persisted
in spite of resolution of clinical disease activity. Similarly, humans
with IBD may have decreased proportions of fecal secondary
BA without significantly altered primary BA (61) and increased
primary BA are reported in people with diarrhea-predominant
irritable bowel syndrome (62).
The ingestion of a high-fat diet (i.e., 75% of total energy
requirement supplied by dietary fat) by healthy dogs has resulted
in changes in fecal BA concentrations (63). In this pilot study,
transitioning from a commercial dry food to a high-fat/low-
fiber ration during a 7 weeks dietary trial increased fecal
concentrations of the secondary BA DCA and UDCA. The
investigators noted that there was significantly higher relative
abundance of an OTU in the family Clostridiaceae (i.e., Clostridia
hiranonis) which is particularly adept at converting primary
BA to secondary BA. The consequences of this and other
diet-associated alterations of the fecal microbiome and BA
metabolome in dogs will require future adequately powered
studies. There are some limitations to this study. First, the
number of patients evaluated in both dog groups was relatively
small and a longitudinal study design evaluating changes in
microbiota and BA in response to treatment should be performed
in the future. Trial enrollment of dogs with DM proved
challenging due to the frequent use of antimicrobials in these
patients (for suspicion of bacterial urinary tract infection or
other unrelated causes) that reduced our sample size. Second,
both cohorts were not fed a standardized diet which may
have influenced microbial composition and the production of
secondary BA. Third, we report data only for fUBA (but not
conjugated BA) which may not provide a complete picture of
BA dysmetabolism present in dogs with DM. That said, we are
unaware of other published methods, beyond those described in
the present study, to measure fecal BA concentrations in healthy
and diseased dogs.
In conclusion, our results indicate that both intestinal
dysbiosis and altered fecal BA levels are present in dogs
with naturally occurring, insulin-dependent DM. Diabetic dogs
demonstrate increased fecal primary (CA) BA and decreased
levels of secondary (LCA) BA. The patterns of microbial
imbalance and impaired BA homeostasis bear strong similarity
to T2DM in humans. The dog represents a novel large
animal model for advancing translational medicine research
efforts (e.g., investigating pathogenesis and therapeutics) in DM
affecting humans.
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